CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-13 | Parikh Asit Director | Purchase | +10,000 | $4.42 | $44K | 85,500 |
| 2025-02-27 | Curran Terrie President and Chief Executive | Grant or award · Stock Option (Right to Buy) | +342,500 | 342,500 | ||
| 2025-02-27 | Henderson Molly CFO and CBO | Grant or award | +72,000 | 165,546 | ||
| 2025-02-27 | Henderson Molly CFO and CBO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-02-27 | Nabulsi Azmi Chief Operating Officer | Grant or award | +79,200 | 312,590 | ||
| 2025-02-27 | Nabulsi Azmi Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-01-21 | Henderson Molly CFO and CBO | Sale | −6,583 | $6.59 | $43K | 93,546 |
| 2025-01-21 | Nabulsi Azmi Chief Operating Officer | Sale | −7,886 | $6.59 | $52K | 233,390 |
| 2025-01-21 | Curran Terrie President and Chief Executive | Sale | −19,109 | $6.59 | $126K | 360,465 |
| 2024-12-19 | Nabulsi Azmi Chief Operating Officer | Sale | −1,118 | $8.00 | $9K | 239,303 |
| 2024-12-19 | Henderson Molly CFO and CBO | Sale | −1,291 | $8.00 | $10K | 98,156 |
| 2024-12-13 | KARBE FRANK Director | Purchase | +12,500 | $7.93 | $99K | 57,000 |
| 2024-12-13 | Parikh Asit Director | Purchase | +10,000 | $8.12 | $81K | 75,500 |
| 2024-09-10 | Parikh Asit Director | Option exercise | +7,500 | $11.72 | $88K | 93,000 |
| 2024-09-10 | Parikh Asit Director | Option exercise · Stock Option (Right to Buy) | −7,500 | 7,500 | ||
| 2024-07-15 | Nabulsi Azmi Chief Operating Officer | Sale | −10,901 | $11.72 | $128K | 240,421 |
| 2024-07-15 | Henderson Molly CFO and CBO | Sale | −4,325 | $11.72 | $51K | 99,447 |
| 2024-07-15 | Curran Terrie President and Chief Executive | Sale | −33,848 | $11.72 | $397K | 377,734 |
| 2024-05-31 | Henderson Molly CFO and CBO | Grant or award | +7,500 | 102,763 | ||
| 2024-05-31 | Nabulsi Azmi Chief Operating Officer | Grant or award | +7,500 | 249,567 |
Page 5 of 19 · 379 trades